Detalles de la búsqueda
1.
Therapeutic Immunization against Glioblastoma.
Int J Mol Sci
; 19(9)2018 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30150597
2.
Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
Cytotherapy
; 16(4): 427-39, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24280238
3.
Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies.
J Neurosurg
; 139(3): 822-830, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738464
4.
Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate.
Autophagy
; 19(12): 3169-3188, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545052
5.
Enhancing brain entry and therapeutic activity of chimeric antigen receptor T cells with intra-arterial NEO100 in a mouse model of CNS lymphoma.
J Neurosurg
; : 1-9, 2023 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38157532
6.
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Front Oncol
; 12: 934638, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837107
7.
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts.
CNS Oncol
; 7(3): CNS22, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30157683
8.
Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report.
Perm J
; 19(2): 41-6, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25785641
9.
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity.
Vaccine
; 33(23): 2690-6, 2015 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25865468
10.
Therapeutic targeting of malignant glioma.
Anticancer Agents Med Chem
; 14(8): 1075-84, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25175690
11.
Exploring the Therapeutic Efficacy of Glioma Vaccines Based on Allo- and Syngeneic Antigens and Distinct Immunological Costimulation Activators.
J Clin Cell Immunol
; Suppl 5: 004, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-24955288
12.
Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Vaccine
; 26(14): 1764-72, 2008 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-18336964
Resultados
1 -
12
de 12
1
Próxima >
>>